Bayer is reshaping its pharmaceutical business with a new operating model designed to enhance collaboration and bring research & development and commercialization closer together. In a recent episode ...

Bayer has cleared out four cancer candidates from its early-stage pipeline, including a STAT3 inhibitor acquired as part of its buyout of Vividion Therapeutics. The Vividion asset in question, called ...

A federal judge in San Francisco gave final approval to a $38 million class action settlement in a case against Bayer over investors’ claims that it didn’t conduct due diligence before making a ...

(Bloomberg) — Bayer AG appointed Judith Hartmann as chief financial officer from June next year in the latest change to the struggling German company’s management team. Hartmann will replace Wolfgang ...

Bayern Munich and Liverpool won the blockbuster matchups in the Champions League on Tuesday. Micky van de Ven might have already scored the competition's goal of the season. With a 2-1 win at ...

Bayer US LLC failed to accommodate a one-time associate director’s prostate cancer and fired him because of his disability, age, and sex, a lawsuit filed in New Jersey federal court says. Jeffrey ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Durham biotech with big-name ...

Given the relatively small size of the HER2-mutant NSCLC population, the market is unlikely to sustain two major long-term competitors. Credit: 9dream studio via Shutterstock. On 18 October 2025 at ...